Structure
& Governance

The Africa Health Research Institute Director, Professor Deenan Pillay, leads the institute and oversees its scientific programmes. The Director is assisted by a Chief Operating Officer, Chief Financial Officer, Chief Information Officer and Senior Advisor.

Leadership

Deenan Pillay

Deenan Pillay

Director

Prof. Deenan Pillay is an academic clinical virologist with a research and clinical interest in HIV transmission, antiviral therapy and drug resistance. He is a Professor in Virology in the University College London Division of Infection & Immunity. His research work at UCL and AHRI focusses on HIV virus evolution, in particular how HIV escapes drug selective pressure. His research spans wet (genomic, phenotypic) and dry (bioinformatics) laboratory approaches, as well as linking in vitro data to national and international population estimates. Prior to his posting as Director of Africa Health Research Institute, he served as Director of the Africa Centre for Population Health. He has held a number of other senior scientific roles, including Head of the Division of Infection and Immunity at UCL, and Director of the UCL Biomedical Research Centre.

Raynold Zondo

Raynold Zondo

Chief Operating Officer

Before joining AHRI in 2018, Raynold Zondo was a Group Executive at the Council for Scientific and Industrial Research (CSIR), a position he held for over a decade. Raynold’s initial degree was in Biochemistry and Mathematics. He also holds a BCom degree in Commercial Law, an MSc in Project
Management and a Master’s in Biotechnology. Previously with Smith & Nephew Pharmaceuticals as a Regulatory Affairs Manager, Raynold joined the CSIR in 2002 as a Quality Assurance Manager. He was appointed Group Manager: Management Services in 2005 and went on to lead the CSIR’s
Shared Services portfolio as a Group Executive from 2007. He is also a former Chairperson of the Board of the South African Quality Institute.

Dilip Kalyan

Dilip Kalyan

Chief Financial Officer

Dilip Kalyan qualified as a Chartered Accountant in 1988. Shortly thereafter, he joined the SA Clothing Industries as a Proactive Accountant where he quickly moved up through the ranks and was appointed Group Financial Director in 1997; a position which he held for 11 years. He was then headhunted to join a startup multi-national engineering company where he was appointed Financial Director responsible for group financial responsibilities. Dilip describes himself as results driven; a strong motivator with good business acumen. At AHRI he is responsible for financial planning, financial record keeping, financial reporting, and the management of financial risks.

Kobus Herbst

Kobus Herbst

Chief Information Officer

Dr Kobus Herbst is a public health specialist. In the early 1990s, he contributed to the establishment of the post-apartheid health system through the development and implementation of ReHMIS (Regional Health Management Information System), the first computerised public health care facility inventory in South Africa. Prior to AHRI's formation, Kobus was Deputy Director of the Africa Centre and also led its demographic surveillance programme. As AHRI's Chief Information Officer, Kobus is responsible for ensuring that information governance and management at the Institute supports and enhances our research mission. He is also Deputy Director of the South African Population Research Infrastructure Network (SAPRIN) at the SAMRC, a large investment by the Department of Science and Technology to integrate the three Health and Demographic Surveillance sites in the country into a common population research infrastructure.

Alan Aderem

Alan Aderem

Senior Advisor

Professor Alan Aderem is an internationally recognised systems biologist, immunologist and cell biologist. He held faculty positions at The Rockefeller University and the University of Washington prior to co-founding the Institute for Systems Biology in 2000. The ISB was the first institute for systems biology worldwide, and Alan served as its Director from its inception until 2011. In 2012, he became President of the Centre for Infectious Disease Research, the largest independent non-profit Institute in the US focused solely on infectious disease research. There he pioneered the fields of Systems Immunology and Systems Vaccinology to accelerate the development of vaccines, drugs and diagnostics. Alan was closely involved in the establishment of K-RITH and served as the Chair of the K-RITH Board of Directors from its inception until 2016. At AHRI, Alan is Senior Advisor to the Director, and is integral to establishing the organisational vision and implementing new research programmes.

Board of Directors

AHRI is governed by a Board of Directors composed of outstanding scientific and global health leaders. The Board meets twice a year and is tasked with reviewing and authorising major institute decisions. Professor Peter Piot currently serves as the Board’s chairman.

Board of Directors

Prof. Hoosen Coovadia

Prof. Hoosen Coovadia

Professor Hoosen (Jerry) Coovadia is an Emeritus Professor of Paediatrics and Child Health and Emeritus Victor Daitz Professor of HIV/Aids research at UKZN. Prof. Coovadia was chairperson of the Mandela government’s first Commission on Maternal and Child Health to design appropriate policies for a new country. He also has had major interests in pursuing justice, democracy, development and freedom during and after apartheid. He headed the largest International Aids Conference to be brought to South Africa and has done much research on prevention of mother to child transmission of HIV. Prof. Coovadia has published more than 327 papers on maternal child health.

Prof. Nelson Sewankambo

Prof. Nelson Sewankambo

Professor Nelson Sewankambo is a Professor of Internal Medicine and former principal of Makerere University College of Health Sciences, an external member of US National Academy of Medicine, a Fellow of African Academy of Sciences, and TWAS. Prof. Sewankambo was among the first scientists to publish data on Aids in Africa and is a researcher of the Rakai Health Sciences program, founded 30 years ago. He has served on numerous local and international advisory committees and Boards. These include the Working Party on the Ethics of Clinical Research in Developing Countries of the Nuffield Council for Bioethics, the Joint Learning Initiative, the WHO African Advisory Committee on Health and Research Development, and the Board of the International Clinical Epidemiology Network.

Prof. Carol Gross

Prof. Carol Gross

Professor Carol Gross is a Professor of Microbiology and Immunology, and Cell and Tissue Biology at the University of California at San Francisco (UCSF). She is a member of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, and a Fellow of the American Academy of Microbiology. Prof. Gross studies bacterial gene control and gene circuits.

Prof. David Lomas

Prof. David Lomas

From August 2015, Professor David Lomas has served as the Vice-Provost (Health) at University College London. Previously, he was Dean of UCL Medical Sciences and Chair of Medicine, a position he held since the start of 2013. An outstanding clinician scientist, Prof. Lomas was also a Professor of Respiratory Biology in the University of Cambridge and Honorary Consultant Physician at Addenbrooke’s and Papworth Hospitals, and Deputy Director of the Cambridge Institute for Medical Research.

Prof. Deresh Ramjugernath

Prof. Deresh Ramjugernath

Professor Deresh Ramjugernath is the Deputy Vice-Chancellor: Research at the University of KwaZulu-Natal (UKZN). He is also a Professor of Chemical Engineering and the Co-Director of the Thermodynamics Research Unit at UKZN. Prof. Ramjugernath is a member of the Academy of Sciences of South Africa, a Fellow of the South African Academy of Engineers, a Fellow of the African Academy of Science, as well as a Fellow of UKZN.

Dr Simon Kay

Dr Simon Kay

As Head of International Operations and Partnerships at Wellcome Trust, Dr Simon Kay leads Wellcome's efforts to build biomedical and health research capacity in Africa and India. Dr Kay has expertise in charitable and not for profit international governance arrangements, and in capacity building in Lower and Middle Income Countries. He is also a Governor at Ardingly College in West Sussex, a Trustee of the Malaria Consortium, a Director of the Africa Research Consortium for Health (ARCH) in Kenya and a member of the Partners' Group which provides governance oversight to the Alliance for Accelerating Excellence in Science in Africa (AESA).

Scientific Advisory Board

AHRI’s Scientific Advisory Board, chaired by Prof. Janet Darbyshire, is composed largely of international experts in HIV and TB research. It meets semi-annually to advise the Director and the science programmes at AHRI.

Scientific Advisory Board

Prof. Gavin Churchyard

Prof. Gavin Churchyard

Professor Gavin Churchyard is a specialist physician, internationally-renowned for his contributions in tuberculosis. He is the founder and CEO of The Aurum Institute NPC, an independent, not for profit South African public benefit organisation that focuses on TB and HIV service delivery, management and research. He is an Honorary Professor at the University of Witwatersrand, School of Public Health and an Honorary Professor at the London School of Hygiene and Tropical medicine. Prof. Churchyard is the principal investigator on a number of TB trials being conducted in South Africa. He has contributed to industry, national and international guidelines for TB and HIV, and has published widely in the areas of TB and HIV treatment and prevention.

Prof. Stewart Cole

Prof. Stewart Cole

Professor Stewart T. Cole is the director of the Global Health Institute. He is an international authority in bacterial genetics and genomics. He was a key member of the team that uncovered the complete DNA sequence of the Aids virus, HIV 1, and of the bacteria that cause TB, among many other important findings. Among the most highly cited TB researchers, Prof. Cole is currently leading an international project to discover new drugs to treat TB. Among many international awards, he is a fellow of the Royal Society.

Prof. Wafaa El-Sadr

Prof. Wafaa El-Sadr

Professor Wafaa El-Sadr is Professor of Epidemiology and Medicine at Columbia’s Mailman School of Public Health and College of Physicians and Surgeons. She is also the founder and director of the International Centre for AIDS Care and Treatment (ICAP) at Columbia University and the Global Health Initiative at the School of Public Health. Through ICAP, large scale programmes have been established in 20 countries in sub Saharan Africa and Asia that integrate research, education, training and practice with a focus on HIV, related conditions and health system strengthening to enable response to diverse health threats. Prof. El-Sadr is also a recognised researcher in the areas of prevention and management of HIV and tuberculosis as well as in implementation research seeking the identification of effective methods to implement and scale-up interventions through rigorous research.

Dr. Gilla Kaplan

Dr. Gilla Kaplan

Dr Gilla Kaplan leads the team that works to accelerate the reduction of TB incidence globally at the Bill & Melinda Gates Foundation. Before this, she was a professor of medicine and associate director at the Public Health Research Institute Centre of the University of Medicine and Dentistry of New Jersey. She is an authority on the host cellular immune response to mycobacterial infections. Dr Kaplan is the recipient of multiple grants from the NIH-NIAID and other foundations for her research.

Prof. Sara Randall

Prof. Sara Randall

Professor Sara Randall is a Professor of Anthropology in the Department of Anthropology at University College London. She has considerable experience of field data collection (both quantitative and qualitative) in Mali, Senegal and Burkina Faso under a range of conditions. Her work focusses on issues such as health behaviour, marital and reproductive decision making, the impact of migration on those left behind as well as trying to understand the determinants of different patterns of demographic dynamics in poor, rural African populations and the interplay between development and demography. Prof Randall's research is currently orientated around unpacking the mismatch between the concepts used in survey data collection and respondents’ own ideas about what is important and their daily realities.

Prof. Greg Towers

Prof. Greg Towers

Professor Greg Towers is a Professor of Molecular Virology and Senior Wellcome Biomedical Research Fellow in the Division of Infection and Immunity at University College London. The Towers Lab aims to understand the molecular details of host virus interactions, and is developing novel inhibitors of viral infection that manipulate viruses’ ability to hide from innate immune pattern recognition receptors. They also aim to use their understanding of innate immune control of HIV-1 to develop novel gene therapy based approaches to treat HIV-1 infection.